BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34013167)

  • 1. Ligand Guided Selection (LIGS) of Artificial Nucleic Acid Ligands against Cell Surface Targets.
    Zumrut HE; Mallikaratchy PR
    ACS Appl Bio Mater; 2020 May; 3():2545-2552. PubMed ID: 34013167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of Aptamers Against Cell Surface Markers Using Ligand-Guided Selection.
    Williams N; Patel R; Mallikaratchy P
    Methods Mol Biol; 2023; 2570():13-38. PubMed ID: 36156771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An
    Williams NB; Batool S; Zumrut HE; Patel R; Sosa G; Jamal M; Mallikaratchy P
    Biochemistry; 2022 Aug; 61(15):1600-1613. PubMed ID: 35829681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of Complex Target SELEX to Identify Aptamers against Mammalian Cell-Surface Antigens.
    Mallikaratchy P
    Molecules; 2017 Jan; 22(2):. PubMed ID: 28146093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural optimization of an aptamer generated from Ligand-Guided Selection (LIGS) resulted in high affinity variant toward mIgM expressed on Burkitt's lymphoma cell lines.
    Zümrüt HE; Batool S; Van N; George S; Bhandari S; Mallikaratchy P
    Biochim Biophys Acta Gen Subj; 2017 Jul; 1861(7):1825-1832. PubMed ID: 28363693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dimerization of an aptamer generated from Ligand-guided selection (LIGS) yields a high affinity scaffold against B-cells.
    Batool S; Argyropoulos KV; Azad R; Okeoma P; Zumrut H; Bhandari S; Dekhang R; Mallikaratchy PR
    Biochim Biophys Acta Gen Subj; 2019 Jan; 1863(1):232-240. PubMed ID: 30342154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating Ligand-Receptor Interactions and In Vitro Evolution for Streamlined Discovery of Artificial Nucleic Acid Ligands.
    Zumrut HE; Batool S; Argyropoulos KV; Williams N; Azad R; Mallikaratchy PR
    Mol Ther Nucleic Acids; 2019 Sep; 17():150-163. PubMed ID: 31255977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand-Guided Selection of Target-Specific Aptamers: A Screening Technology for Identifying Specific Aptamers Against Cell-Surface Proteins.
    Zumrut HE; Ara MN; Fraile M; Maio G; Mallikaratchy P
    Nucleic Acid Ther; 2016 Jun; 26(3):190-8. PubMed ID: 27148897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Advancements in complex target systematic evolution of ligands by exponential enrichment].
    Wu Z; Xue S; Yang Y
    Se Pu; 2018 Oct; 36(10):947-951. PubMed ID: 30378352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selecting Fully-Modified XNA Aptamers Using Synthetic Genetics.
    Taylor AI; Holliger P
    Curr Protoc Chem Biol; 2018 Jun; 10(2):e44. PubMed ID: 29927117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand-Guided Selection with Artificially Expanded Genetic Information Systems against TCR-CD3ε.
    Zumrut H; Yang Z; Williams N; Arizala J; Batool S; Benner SA; Mallikaratchy P
    Biochemistry; 2020 Feb; 59(4):552-562. PubMed ID: 31880917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Capture-SELEX Strategy for Multiplexed Selection of RNA Aptamers Against Small Molecules.
    Lauridsen LH; Doessing HB; Long KS; Nielsen AT
    Methods Mol Biol; 2018; 1671():291-306. PubMed ID: 29170966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Homodimeric Aptamer Variant Generated from Ligand-Guided Selection Activates the T Cell Receptor Cluster of Differentiation 3 Complex.
    Freage L; Jamal D; Williams NB; Mallikaratchy PR
    Mol Ther Nucleic Acids; 2020 Aug; 22():167-178. PubMed ID: 32920262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unraveling Prion Protein Interactions with Aptamers and Other PrP-Binding Nucleic Acids.
    Macedo B; Cordeiro Y
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28513534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SELEX methods on the road to protein targeting with nucleic acid aptamers.
    Bayat P; Nosrati R; Alibolandi M; Rafatpanah H; Abnous K; Khedri M; Ramezani M
    Biochimie; 2018 Nov; 154():132-155. PubMed ID: 30193856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA aptamers: from basic science towards therapy.
    Ulrich H
    Handb Exp Pharmacol; 2006; (173):305-26. PubMed ID: 16594622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection and Application of Aptamers and Intramers.
    Avci-Adali M
    Adv Exp Med Biol; 2016; 917():241-58. PubMed ID: 27236559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aptamers: molecular tools for analytical applications.
    Mairal T; Ozalp VC; Lozano Sánchez P; Mir M; Katakis I; O'Sullivan CK
    Anal Bioanal Chem; 2008 Feb; 390(4):989-1007. PubMed ID: 17581746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA and RNA aptamers: from tools for basic research towards therapeutic applications.
    Ulrich H; Trujillo CA; Nery AA; Alves JM; Majumder P; Resende RR; Martins AH
    Comb Chem High Throughput Screen; 2006 Sep; 9(8):619-32. PubMed ID: 17017882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleic Acid Aptamers as Potential Therapeutic and Diagnostic Agents for Lymphoma.
    Shum KT; Zhou J; Rossi JJ
    J Cancer Ther; 2013 Jun; 4(4):872-890. PubMed ID: 25057429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.